Sharon Reece

Sharon Reece

Auto-generated profile, based on publicly available information

Sharon Reece

College of Medicine, University of Arkansas for Medical Sciences Northwest, 1125 N. College Ave., Fayetteville, AR 72703, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2010 in Journal of Biological Chemistry
Verified
Journal Article
Open access
JDJames J. Donkin
James J. Donkin
SSSophie Stukas
Sophie Stukas
VHVeronica Hirsch-Reinshagen
Veronica Hirsch-Reinshagen
DNDhananjay Namjoshi
Dhananjay Namjoshi
AWAnna Wilkinson
Anna Wilkinson
CWCheryl L. Wellington
Cheryl L. Wellington
The cholesterol transporter ATP-binding cassette transporter A1 (ABCA1) moves lipids onto apolipoproteins including apolipoprotein E (apoE), which is the major cholesterol carrier in the brain and an established genetic risk factor for late-onset Alzheimer disease (AD). In amyloid mouse models of AD, ABCA1 deficiency exacerbates amyloidogenesis, whereas ABCA1 overexpression ameliorates amyloid load, suggesting a role for ABCA1 in Aβ metabolism. Agonists of liver X receptors (LXR), including GW3965, induce transcription of several genes including ABCA1 and apoE, and reduce Aβ levels and improve cognition in AD mice. However, the specific role of ABCA1 in mediating beneficial responses to LXR agonists in AD mice is unknown. We evaluated behavioral and neuropathogical outcomes in GW3965-treated female APP/PS1 mice with and without ABCA1. Treatment of APP/PS1 mice with GW3965 increased ABCA1 and apoE protein levels. ABCA1 was required to observe significantly elevated apoE levels in brain tissue and cerebrospinal fluid upon therapeutic (33 mg/kg/day) GW3965 treatment. At 33 mg/kg/day, GW3965 was also associated with a trend toward redistribution of Aβ to the carbonate-soluble pool independent of ABCA1. APP/PS1 mice treated with either 2.5 or 33 mg/kg/day of GW3965 showed a clear trend toward reduced amyloid burden in hippocampus and whole brain, whereas APP/PS1-treated mice lacking ABCA1 failed to display reduced amyloid load in the whole brain and showed trends toward increased hippocampal amyloid. Treatment of APP/PS1 mice with either dose of GW3965 completely restored novel object recognition memory to wild-type levels, which required ABCA1. These results suggest that ABCA1 contributes to several beneficial effects of the LXR agonist GW3965 in APP/PS1 mice.

12 May 2014 in Canadian Medical Association Journal
Verified
Journal Article
Open access
PDF file
DRDonald A. Redelmeier
Donald A. Redelmeier
SMSharon C. May
Sharon C. May
DTDeva Thiruchelvam
Deva Thiruchelvam
JBJon F. Barrett
Jon F. Barrett
Introduction: Pregnancy causes diverse physiologic and lifestyle changes that may contribute to increased driving and driving error. We compared the risk of a serious motor vehicle crash during the second trimester to the baseline risk before pregnancy. Methods: We conducted a population-based self-matched longitudinal cohort analysis of women who gave birth in Ontario between April 1, 2006, and March 31, 2011. We excluded women less than age 18 years, those living outside Ontario, those who lacked a valid health card identifier under universal insurance, and those under the care of a midwife. The primary outcome was a motor vehicle crash resulting in a visit to an emergency department. Results: A total of 507 262 women gave birth during the study period. These women accounted for 6922 motor vehicle crashes as drivers during the 3-year baseline interval (177 per mo) and 757 motor vehicle crashes as drivers during the second trimester (252 per mo), equivalent to a 42% relative increase (95% confidence interval 32%–53%; p < 0.001). The increased risk extended to diverse populations, varied obstetrical cases and different crash characteristics. The increased risk was largest in the early second trimester and compensated for by the third trimester. No similar increase was observed in crashes as passengers or pedestrians, cases of intentional injury or inadvertent falls, or self-reported risky behaviours. Interpretation: Pregnancy is associated with a substantial risk of a serious motor vehicle crash during the second trimester. This risk merits attention for prenatal care.

25 March 2023 in Infectious Medicine
Verified
Journal Article
Open access
SRSharon Reece
Sharon Reece
SCSheena CarlLee
Sheena CarlLee
ASAaron J. Scott
Aaron J. Scott
DWDon E. Willis
Don E. Willis
BRBrett Rowland
Brett Rowland
PMPearl A. McElfish
Pearl A. McElfish
Despite the United States (US) having an abundant supply of COVID-19 vaccines, vaccination rates lag behind other high-income countries, suggesting that vaccine hesitancy and attitudes play a greater role in public health measures than pure supply and access. With the acknowledgment that vaccination attitudes and status may or may not be correlated, this study examined COVID-19 vaccine hesitancy among vaccinated US adults by asking: 1) What is the prevalence of COVID-19 vaccine hesitancy among the vaccinated? 2) Does COVID-19 vaccine hesitancy vary across sociodemographic characteristics? 3) Does COVID-19 vaccine hesitancy vary by healthcare access and influenza vaccination over the past 5 years? Data were collected through an online survey of 2022 US adults with a final analytic sample of 1383 vaccinated respondents. Overall, 48.8% of vaccinated adults reported some level of hesitancy, while a slight majority reported they were “not at all hesitant”. Younger respondents, women, and Black and American Indian or Alaska Native participants had greater adjusted odds of being more hesitant towards receiving the COVID-19 vaccine. Respondents who had a primary care physician had greater adjusted odds than those who did not have a primary care physician of being more hesitant towards receiving the COVID-19 vaccine. This is the first population-based national sample study examining COVID-19 vaccine hesitancy among vaccinated individuals from subgroups of distinctive backgrounds in order to inform targeted strategies for reducing vaccine hesitancy. Findings can assist in efforts to increase vaccination rates and also decrease vaccine hesitancy at the national level.

12 August 2022 in Medicine
Verified
Journal Article
Open access
RMRamey Moore
Ramey Moore
RPRachel S. Purvis
Rachel S. Purvis
EHEmily Hallgren
Emily Hallgren
SRSharon Md Reece
Sharon Md Reece
APAlan Padilla-Ramos
Alan Padilla-Ramos
PMPearl A. McElfish
Pearl A. McElfish
The COVID-19 pandemic has disrupted the health care system, resulting in decreased health care utilization. During the pandemic, some patients chose to postpone clinic visits or avoid them altogether while health care providers concurrently scaled back their services. As a result, health care has shifted to a greater reliance on telehealth and virtual care. This study uses a qualitative descriptive design, focused on providing summaries of participant experiences of health care and telehealth utilization during the COVID-19 pandemic. Three primary themes emerged during analysis: delayed health care, avoidance of care, and experiences of telehealth. Sub-themes of delayed health care included care delays and scheduling difficulties. Participants reported avoidance of health care due to fear of COVID-19 infection, as well as general changes to care-seeking behaviors. Participants also reported positive experiences with telehealth, with some respondents noting limitations of telehealth systems, such as limitations on procedures and patient-centered monitoring of chronic illness. Our findings support studies that have found both health care delays and changes in health care utilization patterns during the pandemic. Most importantly, this study expands the literature concerning links between fear of COVID-19 and altered care-seeking behaviors, which is the first study to do so focusing on these concerns in the participants’ own words. Finally, while telehealth is promising in preserving continuity of care during pandemics, long-term integration into the health care system is not without challenges, and this study provides insights into how patients experienced telehealth during COVID-19 in their own words. Data collection, survey design, and research priorities for this study were based on input from ongoing community partnerships.

3 November 2022 in Clinical and Translational Science
Verified
Journal Article
Open access
RMRamey Moore
Ramey Moore
RPRachel S. Purvis
Rachel S. Purvis
DWDon Willis
Don Willis
KWKyle C. Worley
Kyle C. Worley
DHDevonte Hervey
Devonte Hervey
PMPearl A. McElfish
Pearl A. McElfish
Vaccination is a strategy for mitigating the impact of coronavirus disease 2019 (COVID‐19) at both the individual and population levels. Vaccine hesitancy is identified as a significant threat to global health by the World Health Organization (WHO). Vaccine hesitancy has been theorized as a continuum encompassing a range of attitudes, beliefs, emotional orientations, ideologies, and health‐seeking behaviors. Individuals who received the COVID‐19 vaccine but also indicated some level of hesitancy about vaccination, or “hesitant adopters,” remain an understudied group. This study uses a qualitative descriptive design to understand motivations to receive the COVID‐19 vaccine among hesitant adopters at various self‐reported levels of hesitancy. We conducted interviews with hesitant adopters (n = 49) to analyze the elements of vaccine hesitancy corresponding to reported levels of COVID‐19 vaccine hesitancy (i.e., “little hesitant,” “somewhat hesitant,” and “very hesitant”). Concerns about side effects are shared across the continuum but are articulated differently at each level of hesitancy. The “little hesitant” relate fears of side effects to their health and a lack of clear information to inform their health decision making, whereas the “very hesitant” articulate the risks of side effects within the frame of conspiracies related to the development, approval, and economics of the COVID‐19 vaccine. Additionally, conspiracy theories generally increase in salience across the continuum, with the “very hesitant” reporting conspiracy theories as the most salient element of vaccine hesitancy. This research presents opportunities for developing targeted interventions for different levels of vaccine hesitancy.

25 February 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
PMPearl A. McElfish
Pearl A. McElfish
DWDon Willis
Don Willis
SSSumit Kamleshkumar Shah
Sumit Kamleshkumar Shah
SRSharon Reece
Sharon Reece
JAJennifer Andersen
Jennifer Andersen
TWT. Scott Warmack
T. Scott Warmack
A cross-sectional survey design was used to assess Arkansas parents’/guardians’ intentions to vaccinate their child against COVID-19. Parents/guardians whose oldest child was age 0–11 years (n = 171) or 12–17 years (n = 198) were recruited between 12 July and 30 July 2021 through random digit dialing. Among parents/guardians with an age-eligible child, age 12–17, 19% reported their child had been vaccinated, and 34% reported they would have their child vaccinated right away. Among parents/guardians with a child aged 0–11, 33% of parents/guardians reported they would have their child vaccinated right away. Twenty-eight percent (28%) of parents/guardians whose oldest child was 12–17 and 26% of parents/guardians whose oldest child was 0–11 reported they would only have their child vaccinated if their school required it; otherwise, they would definitely not vaccinate them. For both groups, parents’/guardians’ education, COVID-19 vaccination status, and COVID-19 vaccine hesitancy were significantly associated with intentions to vaccinate their child. More than a third of parents/guardians whose child was eligible for vaccination at the time of the survey reported they intended to have them vaccinated right away; however, they had not vaccinated their child more than two months after approval. This finding raises questions about the remaining barriers constraining some parents/guardians from vaccinating their child.